Intel loses U.S. patent trial, ordered to pay $2.18 billion to VLSI Tech
- Wall Street slips off record highs, Tesla drops after fatal crash
- IBM (IBM) Tops Q1 EPS by 14c, Revenue Beats
- Tesla's (TSLA) Musk says data logs from crashed vehicle show Autopilot was not enabled, car did not purchase FSD
- Bitcoin (BTC) Price Fell 20% Off the Highs Over the Weekend as Markets Got 'Too Excited' About Coinbase (COIN), Says Mike Novogratz
- GameStop (GME) CEO Gets the Axe as Ryan Cohen Continues to Make His Mark, Analyst Says Co. Will Likely Look to Tech Sector for New Hires
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
(Reuters) - Chipmaker Intel Corp must pay a technology rival $2.18 billion after a federal jury decided that Intel infringed on its patent, a federal court ruled on Tuesday.
Intel infringed two patents related to chip-making owned by VLSI Technology LLC the jury ruled.
In a statement, Michael Stolarski, chief executive of VLSI Technology, said the firm was "pleased that the jury recognized the value of the innovations as reflected in the patents and are extremely happy with the jury verdict.”
The jury found $1.5 billion for all damages caused to VLSI on infringement of the first patent and $675 million for the infringement of the other.
"Intel strongly disagrees with today's jury verdict. We intend to appeal and are confident that we will prevail," the Santa Clara, California-based company said.
Intel's shares closed down 2.6% at $61.24.
(Reporting by Chavi Mehta in Bengaluru and Stephen Nellis in San Francisco; Editing by Shounak Dasgupta)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Philippine hospitals struggle to cope as more severe COVID-19 wave hits
- Iran says 60% enrichment meant to show nuclear prowess, is reversible
- World stocks edge back, bond yields, COVID-19 cases rise
Create E-mail Alert Related CategoriesLitigation, Reuters
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!